Concentric Capital Strategies’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.52M Buy
108,322
+22,463
+26% +$1.02M 0.31% 71
2026
Q1
$3.26M Buy
85,859
+50,564
+143% +$2.13M 0.27% 62
2025
Q4
$1.82M Sell
35,295
-30,374
-46% -$1.86M 0.09% 165
2025
Q3
$4.89M Sell
65,669
-31,854
-33% -$2.34M 0.22% 127
2025
Q2
$7.45M Buy
97,523
+55,185
+130% +$3.97M 0.33% 96
2025
Q1
$2.96M Buy
42,338
+2,192
+5% +$152K 0.28% 63
2024
Q4
$2.46M Sell
40,146
-163,051
-80% -$10.7M 0.11% 157
2024
Q3
$12M Buy
203,197
+104,982
+107% +$5.77M 0.5% 50
2024
Q2
$5.58M Sell
98,215
-24,827
-20% -$1.52M 0.28% 91
2024
Q1
$7.59M Buy
123,042
+20,701
+20% +$1.19M 0.43% 66
2023
Q4
$4.88M Sell
102,341
-57,074
-36% -$2.31M 0.56% 51
2023
Q3
$5.56M Buy
+159,415
New +$5M 0.57% 48

Other funds holding NTNX

Concentric Capital Strategies's NTNX Position: Q2 2026 in Review

Concentric Capital Strategies increased its Nutanix (NTNX) stake by 26% in Q2 2026, buying an estimated $1.02M and bringing the position to 108,322 shares worth $5.52M. The position accounts for 0.31% of the portfolio, ranked #71.

Concentric Capital Strategies first reported a position in NTNX in Q3 2023 and has held it in 12 quarters since. The position peaked at $12M in Q3 2024. 562 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • Concentric Capital Strategies held 108,322 shares of Nutanix worth $5.52M as of Q2 2026.
  • Concentric Capital Strategies bought 22,463 Nutanix shares in Q2 2026, an estimated $1.02M.
  • Nutanix made up 0.31% of Concentric Capital Strategies's portfolio in Q2 2026, its #71 holding.
  • Concentric Capital Strategies first reported a position in Nutanix in Q3 2023 and has held it in 12 quarters since.
  • Concentric Capital Strategies's Nutanix position peaked at $12M in Q3 2024.
  • 562 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.